These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1516215)

  • 21. The physiology of spasticity and its response to therapy.
    Young RR
    Ann N Y Acad Sci; 1988; 531():146-9. PubMed ID: 3382140
    [No Abstract]   [Full Text] [Related]  

  • 22. Novel Treatment Using Intravenous Dantrolene Sodium for Postoperative Exacerbated Spasticity in Multiple Sclerosis: A Case Report.
    Sturgill EL; Wittwer RL
    A A Pract; 2018 Jul; 11(1):25-27. PubMed ID: 29851691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacological treatment of spasticity in multiple sclerosis].
    Heinzlef O; Monteil-Roch I
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S62-8. PubMed ID: 22721367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of dantrolene sodium on spasticity in multiple sclerosis.
    Gelenberg AJ; Poskanzer DC
    Neurology; 1973 Dec; 23(12):1313-5. PubMed ID: 4796610
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
    Stampacchia G; Gerini A; Mazzoleni S
    NeuroRehabilitation; 2016 Apr; 38(4):385-93. PubMed ID: 27061166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing the symptoms of multiple sclerosis: a multimodal approach.
    Crayton HJ; Rossman HS
    Clin Ther; 2006 Apr; 28(4):445-60. PubMed ID: 16750459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug treatment of spasticity.
    Richens A
    Trans Med Soc Lond; 1975-1977; 92-93():127-30. PubMed ID: 1053111
    [No Abstract]   [Full Text] [Related]  

  • 28. [Symptomatic treatment of multiple sclerosis].
    Ayuso-Peralta L; de Andrés C
    Rev Neurol; 2002 Dec 16-31; 35(12):1141-53. PubMed ID: 12497297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.
    Rekand T; Grønning M
    J Rehabil Med; 2011 May; 43(6):511-4. PubMed ID: 21533331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathecal baclofen treatment an option in X-linked adrenoleukodystrophy.
    Hjartarson HT; Ehrstedt C; Tedroff K
    Eur J Paediatr Neurol; 2018 Jan; 22(1):178-181. PubMed ID: 28964670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration.
    Vitkova M; Gdovinova Z; Rosenberger J; Szilasiova J; Nagyová I; Mikula P; Krokavcova M; Groothoff JW; van Dijk JP
    Disabil Health J; 2014 Oct; 7(4):466-71. PubMed ID: 25224987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [When and how to prescribe muscle relaxants in spasticity ?].
    Delwaide PJ; Burton L
    Rev Med Liege; 1981 Apr; 36(7):268-71. PubMed ID: 7291810
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacotherapy of spasticity: some theoretical and practical considerations.
    Rice GP
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):510-2. PubMed ID: 3315153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.
    Skierlo S; Rommer PS; Zettl UK
    Acta Neurol Scand; 2017 Apr; 135(4):394-399. PubMed ID: 27283842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam.
    Schmidt RT; Lee RH; Spehlmann R
    Trans Am Neurol Assoc; 1975; 100():235-7. PubMed ID: 1226625
    [No Abstract]   [Full Text] [Related]  

  • 36. Botulinum toxin in multiple sclerosis.
    Jost WH
    J Neurol; 2006 Feb; 253 Suppl 1():I16-20. PubMed ID: 16477480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of baclofen in treatment of spasticity in multiple sclerosis.
    Sawa GM; Paty DW
    Can J Neurol Sci; 1979 Aug; 6(3):351-4. PubMed ID: 385132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mixed treatment comparison on efficacy and safety of treatments for spasticity caused by multiple sclerosis: a systematic review and network meta-analysis.
    Fu X; Wang Y; Wang C; Wu H; Li J; Li M; Ma Q; Yang W
    Clin Rehabil; 2018 Jun; 32(6):713-721. PubMed ID: 29582713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment patterns of multiple sclerosis patients: a comparison of veterans and non-veterans using the NARCOMS registry.
    Lo AC; Hadjimichael O; Vollmer TL
    Mult Scler; 2005 Feb; 11(1):33-40. PubMed ID: 15732264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal baclofen for muscle spasticity and pain--two case reports.
    Al Khudhairi D; Rababa A; Saddiqui MN
    Middle East J Anaesthesiol; 2006 Jun; 18(5):971-6. PubMed ID: 17094537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.